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Abstract 
The growth of research in the field of exercise oncology has resulted in a large evidence base for the role 
of physical activity in preventing and managing cancer outcomes. Nonetheless, there remain many 
unanswered questions across the multidisciplinary field. This study aimed to determine the priority 
research questions within exercise oncology using a systematic consensus method. Forty-seven exercise 
oncology experts engaged in the five-step process of the Nominal Group Technique to generate a list of 
research questions in small groups and rank the 10 most important. One hundred questions resulted 
from the process and fifteen received total scores (sum of ranks) of at least 50 from a maximum score of 
470. The highest ranked question (score of 125) related to the identification of functional markers of 
recovery. The next five questions concerned minimum exercise parameters, health professional 
education, translation of behavioural interventions, effects of exercise on the tumour microenvironment 
and development of in vitro models to study the impact of exercise on cancer cell growth and metastasis. 
The study has demonstrated the importance of future research across all disciplinary areas of exercise 
oncology and identified the priority questions to which resources might be directed. 
Key words: physical activity, cancer, evidence, consensus   
Introduction 
The field of exercise oncology has grown rapidly 
in recent years and a substantial body of research has 
accumulated for a role of physical activity in cancer 
prevention and survivorship outcomes. Most research 
on risk reduction relies on observational epidemio-
logical studies of total physical activity undertaken 
across multiple domains (e.g. recreation, occupation, 
and household, commuting). For research on patient 
outcomes, experimental studies of structured exercise 
interventions are used. Studies of physical inactivity 
as a risk factor have been accruing since 1962 (1) 
resulting in moderate to strong evidence for several 
common cancers (2,3). Meanwhile, trials of exercise as 
an intervention for managing treatment side-effects 
emerged in the 1980s (4,5). The large volume of 
research generated since these seminal studies has led 
to evidence-based exercise guidelines for improving 
aspects of physical function and quality of life (6,7). 
Alongside these health and wellbeing outcomes, 
interest has grown in the potential for exercise to 
influence disease progression and survival. An 
encouraging number of studies have provided 
preliminary evidence that physical activity performed 
after cancer diagnosis reduces risk of recurrence and 
mortality (3,8). 
Despite the considerable progress made in 
exercise oncology research, it is widely recognised 
that there are multiple gaps in the current under-
standing of how to optimise the use of exercise for 
cancer prevention or recovery (9). Exercise oncology is 
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a multidisciplinary field and research can be broadly 
categorised into three main areas: 1) cellular and 
molecular; 2) clinical; and 3) behavioural.  
Cellular and molecular exercise oncology 
There are a number of studies into the molecular 
mechanisms underpinning the impact of exercise on 
the tumour itself, yet these are still relatively poorly 
understood (reviewed in 8). Many of these studies are 
undertaken in animal models of exercise, for example, 
using voluntary running wheels, forced swimming 
and forced running on a rodent treadmill, to establish 
the effects that exercise has on the growth of 
xenografted human tumours, carcinogen-induced or 
spontaneously induced tumours in the rodent model 
(11–13). However, translating these observations from 
animal model to the in vivo human setting is difficult 
due to interspecies variation, and the effect of a 
heterologous tumour microenvironment. Fewer 
studies exist that investigate the impact of human 
serum extracted following exercise interventions on 
cancer cell growth in vitro (14–16), but as yet, there is 
no viable in vitro system for modelling the effects of 
exercise on cancer. With the advent of 3D tumour 
models, bioengineered skeletal muscle tissue that can 
be electrically and mechanically stimulated to mimic 
exercise, and microfluidics devices designed to 
culture multiple tissue types within a controlled 
environment, there is great potential for developing 
such in vitro systems in the future. 
Clinical exercise oncology 
More than 2500 clinical trials have been 
published providing collective evidence of the 
benefits of exercise for patient and disease outcomes 
(6). Several authors have highlighted the limitations of 
the evidence base in disproportionately focusing on 
patients with more common cancers (17,18). 
Additionally, the heterogeneity of exercise 
interventions in terms of mode, duration and delivery 
makes it difficult to provide precise conclusions about 
exercise efficacy for specific outcomes, although 
recommendations have been possible for some 
outcomes (6). Recent work in prehabilitation exercise 
has provided preliminary evidence for faster return of 
physical function, fewer postoperative complications 
and shorter hospitalisations (19). To date though there 
are no data on the impact on treatment success or 
changes in disease markers.  
Behavioural exercise oncology 
The clinical evidence of exercise having positive 
effects for a range of cancer control outcomes is now 
substantial. In order to achieve these benefits, 
individuals must be able to adopt and maintain 
regular exercise. Behavioural researchers have 
demonstrated that levels of physical activity are low 
during and after cancer treatment and remain low in 
the longer term (20–22). Few reliable predictors of 
physical activity behaviour in this population have 
been identified with barriers to participation tending 
to match those reported in general population sam-
ples (23,24). Interventions incorporating behaviour 
change techniques have been specifically designed to 
support exercise after a cancer diagnosis. Existing 
studies have had limited success in changing 
behaviour (25), and the challenge of exercise promo-
tion remains a strong focus of behavioural research. 
Research priorities 
There is general recognition among exercise 
oncology researchers of the need for greater 
investigation of this important subject and several 
authors have suggested future research directions 
(8,9,26). With there being countless unanswered 
questions across this multidisciplinary field, it is 
difficult for researchers and funders to decide where 
to invest resources. Therefore, this study aimed to 
determine the priority research questions within 
across all areas of exercise oncology using a 
systematic consensus method.   
Methods 
Design 
The study was reviewed and approved by 
Loughborough University Ethics Approvals (Human 
Participants) Sub-Committee and all participants 
provided written informed consent. The Nominal 
Group Technique was adopted to determine the 
consensus among exercise oncology researchers on 
the priority questions for the field. The Nominal 
Group Technique is a structured consensus method 
that allows all participants an equal opportunity to 
contribute and employs a quantitative ranking system 
to establish priority items. This approach has been 
widely used in health contexts when participants are 
in a single location and has the advantage of leading 
to rapid results (27).  
Participants 
All 50 delegates of a two-day symposium on 
exercise oncology were invited to take part in the 
consensus study and 47 participated. The other three 
delegates had to leave before the consensus task was 
completed. Delegates were all academics and/or 
practitioners working in the field of physical activity 
and cancer who were invited to attend the 
symposium due to their expertise on the subject. All 
participants possessed doctoral degrees (n=21), or 
medical (n=9) or professional (n=12) qualifications or 
were working towards doctorates (n=5). They worked 
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at 36 different institutions from Europe and North 
America with disciplinary backgrounds in molecular 
biology (n=5), physiology (n=7), medicine (n=5), 
oncology (n=4), epidemiology (n=3), nursing (n=1), 
psychology (n=7), dietetics (n=4), and physiotherapy 
(n=7).  
Procedures 
The symposium included invited presentations 
by three international experts in exercise oncology 
followed by an open discussion. Study participants 
were allocated to one of six facilitated groups with 
seven to eight members for the five-step consensus 
study. The first step involved outlining to all 
participants the purpose and procedures of the study. 
In step two, participants were asked to spend 10 
minutes silently thinking of possible questions that 
should be addressed in future research and write each 
one individually on sticky note paper. During step 
three participants took it in turns to read out one 
question and pass it to the facilitator to place on a flip 
chart. This process continued until all questions 
generated had been added to the flip chart. Step four 
involved the group discussing each question to ensure 
its meaning was clear and rephrasing if necessary. 
Any duplicate questions were removed if all group 
members agreed. The questions from all six groups 
were then amalgamated and typed as a single list with 
any repeated questions across groups removed. In the 
fifth step of the process, participants were given a 
printed copy of the question list and asked to rank up 
to ten items for importance (a score of 10 indicated the 
most important question). Analysis involved 
summing the sample scores for each question and 
sorting into descending order. The total score possible 
for any item was 470 (a maximum score of 10 by all 47 
participants).  
Results 
A total of 100 individual research questions were 
generated across the six groups (Table S1). The 15 
highest ranked questions which all received a score of 
at least 50 are presented in Table 1. A visual 
representation summarising these questions is 
presented in Figure 1 reflecting their priority status 
and cellular/molecular, clinical or behavioural focus.  
Discussion 
Although there has been considerable growth in 
exercise oncology research, there remain multiple 
gaps in the knowledge base to be addressed. Other 
authors have proposed key research directions for the 
field (8,9,26) and this study has used an established 
systematic process with a large sample of 
multidisciplinary experts to provide consensus on the 
current priorities. The results generated important 
research question across all areas of exercise oncology: 
clinical, behavioural, and cellular/molecular.  
Clinical exercise oncology research priorities 
The highest ranked question related to 
identifying markers of return to normal function 
post-therapy. A large body of trials has investigated 
the effects of exercise interventions on functional 
outcomes. Significant improvements in 
cardiorespiratory fitness, upper and lower body 
strength, and symptoms of fatigue have been 
observed from aerobic, resistance or combined 
exercise programs (18). However, whether these or 
other outcomes can be used to benchmark recovery 
status is unclear. Preliminary studies indicate that 
measures of exercise capacity may contribute to 
prognosis predictions for advanced lung cancers 
(28,29). Meanwhile, in gerontology there is increasing 
evidence of grip strength as a marker of frailty (30), 
brain health (31) and mortality (32). Identifying 
simple, reliable and valid functional markers that are 
feasible for oncology practice may help inform 
personalised care to enhance health, quality of life, 
and survival outcomes for patients. 
 
Table 1. Fifteen highest ranked research questions  
Rank Score Question  Question 
number 
1 125 What markers reflect changes in the ability of patients to 
return to "normal" function after cancer therapy? 
7 
2 94 How much physical activity is enough – dose-response 
intensity and amount?  
72 
3= 70 What type of support/training/education for health care 
professionals is required to improve their confidence and 
competence in delivering physical activity interventions? 
24 
3= 70 How do we translate effective physical activity behaviour 
change interventions into real world settings? 
30 
5 69 What effect does a combined programme of exercise have 
on the tumour microenvironment? 
15 
6 64 How do we develop an in vitro model for unpicking 
molecular mechanisms underpinning the protective effects 
of physical activity on cancer and the harmful effects of 
adiposity on cancer? 
11 
7= 63 Does perioperative exercise have a long-term effect on 
biological markers and cancer recurrence long term? 
17 
7= 63 What is the optimum timing of exercise pre-chemotherapy 
to increase efficacy/toxicity? 
51 
9 59 Does a single bout of exercise modify tumour activity - at a 
single cell level - in human models of cancer? 
13 
10= 58 How does the ageing immune system modify the viability 
of exercise? 
14 
10= 58 What is the impact of a structured exercise program on 
time to treatment failure in patients with metastatic/ 
advanced disease? 
60 
12 56 Can we develop better biomarkers in the causative 
pathway for specific cancers for use in clinical trials? 
16 
13 55 What effect does the type of exercise (e.g. high intensity 
interval training, strength training) have on gene 
expression and outcome? 
18 
14 53 Is resistance exercise useful in combatting cancer cachexia? 64 
15 51 What is the long-term impact of participation in a 
rehabilitation programme for individuals who have 
completed cancer treatment in terms of cancer recurrence, 
cancer survival and quality of life? 
31 
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The second highest priority question related to 
minimum exercise parameters. There is limited 
evidence of the mode, frequency, intensity, or 
duration of physical activity required for primary 
prevention or for post-diagnosis outcomes although 
considerable progress has been made. Three 
comprehensive reviews of the epidemiological 
research (2,3,33) suggested that a dose-response 
relationship was evident for a few cancer sites, but 
that it is not yet possible to precisely specify the 
physical activity variables associated with risk 
reduction. Similarly, an international consensus 
statement based on an evidence review of cancer 
survivorship outcomes (6) was able to include 
exercise prescription guidance for some outcomes 
(physical function, fatigue, quality of life, mental 
health). For other outcomes, the authors highlighted 
the need for continued research to enable greater 
precision with exercise recommendations. Identifying 
optimal exercise prescription variable was proposed 
as a research priority in Courneya et al.’s discussion of 
the evidence for physical activity and survivorship in 
2015 (26). The results of the current study indicate that 
this question remains one of the most important. 
Behavioural exercise oncology priorities 
Two questions were ranked equal third highest 
priority, both relating to behavioural science. One 
focused on the support and education of healthcare 
professionals to deliver interventions. Several studies 
have examined the experiences of oncology staff 
regarding physical activity promotion among 
patients. Surveys from the UK (34,35), USA (36), 
Canada (37) and one with an international sample (38) 
have demonstrated favourable beliefs among 
healthcare professionals about the importance of 
physical activity. The proportion of oncologists who 
regularly discussed physical activity with patients 
ranged from 43% (37) to 64% (36). The strongest 
barriers to discussing this subject with patients were 
lack of time, expertise, and referral pathways (38). 
These studies confirm the importance of research to 
ascertain which healthcare staffs are best positioned to 
advise patients about physical activity, and what 
support or education is required.  
The other behavioural research question referred 
to the translation of effective behaviour change 
interventions into real world settings. Exercise is a 
challenging behaviour to adopt and maintain and 
many studies have examined interventions to 
encourage regular exercise or general 
physical activity during or after cancer 
treatment. A systematic review of 27 
randomised controlled trials suggested that 
meaningful increases in exercise could be 
achieved through a range of intervention 
approaches (39). These included offering 
printed or online resources, telephone 
counselling, and providing supervised 
exercise sessions. The behaviour change 
techniques associated with successful 
findings were social support, graded tasks 
and action planning. As the evidence base 
strengthens, it will be important to translate 
these research-based interventions into 
community or clinical settings.  
Cellular and molecular exercise 
oncology priorities 
Underpinning the behavioural and 
clinical research priorities is our under-
standing of the molecular mechanisms that 
govern the protective effects of exercise 
against primary cancer risk, tumour 
growth and secondary metastases. The next 
two questions, ranked fifth and sixth, 
related to the tumour microenvironment 
and modelling the effects of cancer in vitro. 
Oncologists are becoming increasingly 
aware of the need to “treat the terrain, not 
 
 
Figure 1. Venn diagram summarising the distribution of the highest priority research 
questions across each area of exercise oncology. Number (#) refers to question ranking. Circle 
sizes reflect the relative weighting of each the three broad areas. The specific position of individual 
questions within the circle has no significance. 
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the tumour” yet surprisingly little is known about 
how exercise modulates the function of cells in distant 
tissues away from those directly involved in the 
exercise response (40). In a comprehensive review, 
Koelwyn et al. (2017) discuss numerous avenues by 
which exercise might re-programme the tumour 
microenvironment. The authors note that there is a 
dearth of research in this area, confirming the 
importance of developing studies to focus on the 
effects of exercise on the tumour microenvironment 
(41). 
The second highest priority question in this area, 
ranked sixth overall, centred around the need for a 
suitable in vitro model for understanding the 
molecular mechanisms involved in exercise-mediated 
cancer protection and the harmful effects of adiposity 
on cancer. Designing an accurate model raises a 
number of additional questions, including how to 
accurately recapitulate the tumour microenviron-
ment, how to authentically recreate the effects of 
exercise, and how to measure the impact of this 
exercise model on tumour growth and metastasis. 
Studies in humans are fraught with multiple con-
founding factors, including the impact of any dietary 
alterations, age, gender and ethnicity, as well as the 
genetic and epigenetic differences that accompany 
these features. The next best alternative – performing 
studies in mice – has its own disadvantages (42). The 
paucity of research in this area can, in part, be 
attributed to the lack of a reliable, repeatable, scalable 
model for investigation, highlighting the importance 
of focused efforts to developing such a model.  
Whilst in vitro models present an excellent 
low-cost alternative to identifying the molecular 
events that govern tumour growth and metastasis in 
response to exercise interventions, conventional 2D 
monolayer cultures are not representative of the in 
vivo environment. Therefore, there has been a drive 
towards developing 3D tumour models in recent 
years (43). Exploiting these advances in 3D cell culture 
models could lend itself to deepening our 
understanding of the molecular impact of exercise on 
cancer cell growth and metastasis, and ultimately aid 
the design and development of appropriate exercise 
interventions for specific cancers.  
Limitations 
Although this study used an established 
systematic consensus method to generate data from a 
large multidisciplinary sample of experts, there are 
limitations to acknowledge. Firstly, the symposium 
was conducted at a single site in the United Kingdom, 
therefore not every invitee was able to attend. 
Moreover, symposium places were limited to 50 
hence the 47 delegates who participated in this 
consensus process only represented a small 
proportion of the international pool of expertise. 
Conclusion  
This consensus study provides agreement 
among a large group of experts on the priority 
questions in the current exercise oncology landscape, 
and therefore the need for further investigation of this 
important field. Whilst the need for functional clinical 
markers was identified as the highest priority 
research question, the similar rankings between the 
next five questions demonstrates the near equal 
importance of each area of exercise oncology research: 
clinical, behavioural and cellular/molecular. There is 
a great need to understand the impact of exercise on 
the tumour itself, the tumour microenvironment, 
patient prognosis and the impact on chemothera-
peutic effectiveness. Progress in these areas will 
enable the development of exercise prescriptions for 
specific cancers in different populations that can be 
effectively translated into practice.  
Supplementary Material  
Supplementary table S1.  
http://www.jcancer.org/v11p2702s1.pdf  
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